{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:44:13Z","timestamp":1793198653133,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.81672335"],"award-info":[{"award-number":["NO.81672335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.81672350"],"award-info":[{"award-number":["NO.81672350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872225"],"award-info":[{"award-number":["81872225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"crossref","award":["YG2016ZD10"],"award-info":[{"award-number":["YG2016ZD10"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Circular RNAs (circRNAs) play a critical regulatory role in cancer progression. However, the underlying mechanisms of circRNAs in hepatocellular carcinoma (HCC) metastasis remain mostly unknown.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Has_circ_0003998 (circ0003998) was identified by RNAs sequencing in HCC patients with \/without portal vein tumor thrombus (PVTT) metastasis. The expression level of circ0003998 was further detected by in situ hybridization on tissues microarray (ISH-TMA) and qRT-PCR in 25 HCC patients with PVTT metastasis. Moreover, the 25 HCC patients with PVTT metastasis and 50 HCC patients without PVTT metastasis were recruited together to analyze the correlation between circ0003998 expression and HCC clinical characteristics. Transwell, migration and CCK8 assays, as well as nude mice model of lung or liver metastasis were used to evaluate the role of circ0003998 in epithelial to mesenchymal transition (EMT) in HCC. The regulatory mechanisms of circ0003998 in miR-143-3p and PCBP1 were determined by dual-luciferase reporter assay, nuclear-cytoplasmic fractionation, fluorescent in situ hybridization, RNA pull- down, microRNA sequence, western blot and RNA immunoprecipitation.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Compared with adjacent normal liver tissues (ANL), circ0003998 expression was significantly upregulated in PVTT tissues and HCC tissues, and its expression correlates with the aggressive characteristics of HCC patients. Further assays suggested that circ0003998 promoted EMT of HCC both in vitro and in vivo. Mechanistically, our data indicated that circ0003998 may act as a ceRNA (competing endogenous RNA) of microRNA-143-3p to relieve the repressive effect on EMT-related stimulator, FOSL2; meanwhile, circ0003998 could bind with PCBP1-poly(rC) binding protein 1 (PCBP1) to increase the expression level of EMT-related genes, CD44v6.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Circ0003998 promotes EMT of HCC by circ0003998\/miR-143-3p\/FOSL2 axis and circ0003998 \/PCBP1\/CD44v6 axis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13046-020-01576-0","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T12:02:58Z","timestamp":1592395378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1"],"prefix":"10.1186","volume":"39","author":[{"given":"Li-na","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-lei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou-feng","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-hua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6927-6297","authenticated-orcid":false,"given":"Hong-li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"1576_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. hepatocellular Carcinoma. N Engl J Med. 2019;380:1450\u201362..","journal-title":"N Engl J Med"},{"key":"1576_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ccr.2006.06.016","volume":"10","author":"A Budhu","year":"2006","unstructured":"Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell. 2006;10:99\u2013111..","journal-title":"Cancer Cell"},{"key":"1576_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1576_CR4","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1152\/physrev.00021.2018","volume":"99","author":"S Piera-Velazquez","year":"2019","unstructured":"Piera-Velazquez S, Jimenez SA. Endothelial to Mesenchymal transition: role in physiology and in the pathogenesis of human diseases. Physiol Rev. 2019;99:1281\u2013324.","journal-title":"Physiol Rev"},{"key":"1576_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71:428\u201342.","journal-title":"Mol Cell"},{"key":"1576_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391.","journal-title":"Nat Rev Genet"},{"key":"1576_CR7","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo JN, Cieslik M, Zhang Y, Shukla S, Xiao L, Zhang Y, Wu YM, Dhanasekaran SM, Engelke CG, Cao X, et al. The landscape of circular RNA in Cancer. Cell. 2019;176:869\u201381 e13.","journal-title":"Cell."},{"key":"1576_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrgastro.2017.169","volume":"15","author":"CM Wong","year":"2018","unstructured":"Wong CM, Tsang FH, Ng IO. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nat Rev Gastroenterol Hepatol. 2018;15:137\u201351.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1576_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2018.10.040","volume":"442","author":"J Fang","year":"2019","unstructured":"Fang J, Hong H, Xue X, Zhu X, Jiang L, Qin M, Liang H, Gao L. A novel circular RNA, circFAT1(e2), inhibits gastric cancer progression by targeting miR-548g in the cytoplasm and interacting with YBX1 in the nucleus. Cancer Lett. 2019;442:222\u201332.","journal-title":"Cancer Lett"},{"key":"1576_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2019.06.018","volume":"460","author":"F Zheng","year":"2019","unstructured":"Zheng F, Wang M, Li Y, Huang C, Tao D, Xie F, Zhang H, Sun J, Zhang C, Gu C, et al. CircNR3C1 inhibits proliferation of bladder cancer cells by sponging miR-27a-3p and downregulating cyclin D1 expression. Cancer Lett. 2019;460:139\u201351.","journal-title":"Cancer Lett"},{"key":"1576_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ebiom.2019.05.032","volume":"44","author":"S Wei","year":"2019","unstructured":"Wei S, Zheng Y, Jiang Y, Li X, Geng J, Shen Y, Li Q, Wang X, Zhao C, Chen Y, et al. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p. EBioMedicine. 2019;44:182\u201393.","journal-title":"EBioMedicine"},{"key":"1576_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32:453\u201361.","journal-title":"Nat Biotechnol"},{"key":"1576_CR13","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jhep.2018.01.012","volume":"68","author":"J Yu","year":"2018","unstructured":"Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma JZ, Sun SH, Yang F, Zhou WP. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68:1214\u201327.","journal-title":"J Hepatol"},{"key":"1576_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.omtn.2019.05.007","volume":"17","author":"Z Li","year":"2019","unstructured":"Li Z, Niu H, Qin Q, Yang S, Wang Q, Yu C, Wei Z, Jin Z, Wang X, Yang A, et al. lncRNA UCA1 mediates resistance to Cisplatin by regulating the miR-143\/FOSL2-signaling pathway in ovarian Cancer. Mol Ther Nucleic Acids. 2019;17:92\u2013101.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1576_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.biopha.2018.07.151","volume":"107","author":"L Sun","year":"2018","unstructured":"Sun L, Guo Z, Sun J, Li J, Dong Z, Zhang Y, Chen J, Kan Q, Yu Z. MiR-133a acts as an anti-oncogene in hepatocellular carcinoma by inhibiting FOSL2 through TGF-beta\/Smad3 signaling pathway. Biomed Pharmacother. 2018;107:168\u201376.","journal-title":"Biomed Pharmacother"},{"key":"1576_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112150","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Sun D, Wang Y, Ren F, Pang S, Wang D, Xu S. FOSL2 positively regulates TGF-beta1 signalling in non-small cell lung cancer. PLoS One. 2014;9:e112150.","journal-title":"PLoS One"},{"key":"1576_CR17","doi-asserted-by":"crossref","unstructured":"Zang J, Lu D, Xu A. The interaction of circRNAs and RNA binding proteins: An important part of circRNA maintenance and function. J Neurosci Res.\u00a02020;98(1).","DOI":"10.1002\/jnr.24356"},{"key":"1576_CR18","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1159\/000492315","volume":"48","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Meng L, Xiao L, Liu R, Li Z, Wang YL. The RNA-binding protein PCBP1 functions as a tumor suppressor in prostate Cancer by inhibiting mitogen activated protein kinase 1. Cell Physiol Biochem. 2018;48:1747\u201354.","journal-title":"Cell Physiol Biochem"},{"key":"1576_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3892\/ijo.2017.4018","volume":"51","author":"P Jiang","year":"2017","unstructured":"Jiang P, Li Z, Tian F, Li X, Yang J. Fyn\/heterogeneous nuclear ribonucleoprotein E1 signaling regulates pancreatic cancer metastasis by affecting the alternative splicing of integrin beta1. Int J Oncol. 2017;51:169\u201383.","journal-title":"Int J Oncol"},{"key":"1576_CR20","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.7150\/ijbs.33103","volume":"15","author":"X Wang","year":"2019","unstructured":"Wang X, Guo J, Che X, Jia R. PCBP1 inhibits the expression of oncogenic STAT3 isoform by targeting alternative splicing of STAT3 exon 23. Int J Biol Sci. 2019;15:1177\u201386.","journal-title":"Int J Biol Sci"},{"key":"1576_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/ncb2029","volume":"12","author":"A Chaudhury","year":"2010","unstructured":"Chaudhury A, Hussey GS, Ray PS, Jin G, Fox PL, Howe PH. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol. 2010;12:286\u201393.","journal-title":"Nat Cell Biol"},{"key":"1576_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biomaterials.2016.04.016","volume":"98","author":"C Branco da Cunha","year":"2016","unstructured":"Branco da Cunha C, Klumpers DD, Koshy ST, Weaver JC, Chaudhuri O, Seruca R, Carneiro F, Granja PL, Mooney DJ. CD44 alternative splicing in gastric cancer cells is regulated by culture dimensionality and matrix stiffness. Biomaterials. 2016;98:152\u201362.","journal-title":"Biomaterials"},{"key":"1576_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s12032-015-0593-z","volume":"32","author":"JR Hernandez","year":"2015","unstructured":"Hernandez JR, Kim JJ, Verdone JE, Liu X, Torga G, Pienta KJ, Mooney SM. Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts. Med Oncol. 2015;32:159.","journal-title":"Med Oncol"},{"key":"1576_CR24","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.2147\/OTT.S174750","volume":"11","author":"W Yu","year":"2018","unstructured":"Yu W, Jiang H, Zhang H, Li J. Hsa_circ_0003998 promotes cell proliferation and invasion by targeting miR-326 in non-small cell lung cancer. Onco Targets Ther. 2018;11:5569\u201377.","journal-title":"Onco Targets Ther."},{"key":"1576_CR25","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.2147\/OTT.S210363","volume":"12","author":"GL Qiao","year":"2019","unstructured":"Qiao GL, Chen L, Jiang WH, Yang C, Yang CM, Song LN, Chen Y, Yan HL, Ma LJ. Hsa_circ_0003998 may be used as a new biomarker for the diagnosis and prognosis of hepatocellular carcinoma. Onco Targets Ther. 2019;12:5849\u201360.","journal-title":"Onco Targets Ther"},{"key":"1576_CR26","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41419-017-0258-2","volume":"9","author":"YP Jin","year":"2018","unstructured":"Jin YP, Hu YP, Wu XS, Wu YS, Ye YY, Li HF, Liu YC, Jiang L, Liu FT, Zhang YJ, et al. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K\/AKT pathway in gallbladder carcinoma. Cell Death Dis. 2018;9:182.","journal-title":"Cell Death Dis"},{"key":"1576_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.biochi.2018.01.003","volume":"147","author":"C Xia","year":"2018","unstructured":"Xia C, Yang Y, Kong F, Kong Q, Shan C. MiR-143-3p inhibits the proliferation, cell migration and invasion of human breast cancer cells by modulating the expression of MAPK7. Biochimie. 2018;147:98\u2013104.","journal-title":"Biochimie."},{"key":"1576_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.biopha.2017.04.060","volume":"91","author":"L Karimi","year":"2017","unstructured":"Karimi L, Mansoori B, Shanebandi D, Mohammadi A, Aghapour M, Baradaran B. Function of microRNA-143 in different signal pathways in cancer: new insights into cancer therapy. Biomed Pharmacother. 2017;91:121\u201331.","journal-title":"Biomed Pharmacother"},{"key":"1576_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.bcp.2018.08.008","volume":"156","author":"E Panza","year":"2018","unstructured":"Panza E, Ercolano G, De Cicco P, Armogida C, Scognamiglio G, Botti G, Cirino G, Ianaro A. MicroRNA-143-3p inhibits growth and invasiveness of melanoma cells by targeting cyclooxygenase-2 and inversely correlates with malignant melanoma progression. Biochem Pharmacol. 2018;156:52\u20139.","journal-title":"Biochem Pharmacol"},{"key":"1576_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/cas.13910","volume":"110","author":"L Guo","year":"2019","unstructured":"Guo L, Fu J, Sun S, Zhu M, Zhang L, Niu H, Chen Z, Zhang Y, Guo L, Wang S. MicroRNA-143-3p inhibits colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer Sci. 2019;110:805\u201316.","journal-title":"Cancer Sci"},{"key":"1576_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-016-0533-3","volume":"15","author":"Z He","year":"2016","unstructured":"He Z, Yi J, Liu X, Chen J, Han S, Jin L, Chen L, Song H. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma. Mol Cancer. 2016;15:51.","journal-title":"Mol Cancer"},{"key":"1576_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12943-018-0933-7","volume":"18","author":"R Yang","year":"2019","unstructured":"Yang R, Xing L, Zheng X, Sun Y, Wang X, Chen J. The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression. Mol Cancer. 2019;18:4.","journal-title":"Mol Cancer"},{"key":"1576_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-019-1031-1","volume":"18","author":"PF Zhang","year":"2019","unstructured":"Zhang PF, Wei CY, Huang XY, Peng R, Yang X, Lu JC, Zhang C, Gao C, Cai JB, Gao PT, et al. Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression. Mol Cancer. 2019;18:105.","journal-title":"Mol Cancer"},{"key":"1576_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41598-017-18739-3","volume":"8","author":"X Sun","year":"2018","unstructured":"Sun X, Dai G, Yu L, Hu Q, Chen J, Guo W. MiR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2. Sci Rep. 2018;8:606.","journal-title":"Sci Rep"},{"key":"1576_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100836","volume":"38","author":"IL Patop","year":"2019","unstructured":"Patop IL, Wust S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38:e100836.","journal-title":"EMBO J"},{"key":"1576_CR36","doi-asserted-by":"publisher","first-page":"5866","DOI":"10.1073\/pnas.0701065104","volume":"104","author":"Q Meng","year":"2007","unstructured":"Meng Q, Rayala SK, Gururaj AE, Talukder AH, O'Malley BW, Kumar R. Signaling dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1. Proc Natl Acad Sci. 2007;104:5866\u201371.","journal-title":"Proc Natl Acad Sci"},{"key":"1576_CR37","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1093\/nar\/gkw241","volume":"44","author":"AS Brown","year":"2016","unstructured":"Brown AS, Mohanty BK, Howe PH. Identification and characterization of an hnRNP E1 translational silencing motif. Nucleic Acids Res. 2016;44:5892\u2013907.","journal-title":"Nucleic Acids Res"},{"key":"1576_CR38","doi-asserted-by":"crossref","unstructured":"Zhang ZZ, Shen ZY, Shen YY, Zhao EH, Wang M, Wang CJ, Cao H, Xu J. HOTAIR long noncoding RNA promotes gastric Cancer metastasis through suppression of poly r(C)-binding protein (PCBP) 1. Mol Cancer Ther. 2015;14:1162\u201370.","DOI":"10.1158\/1535-7163.MCT-14-0695"},{"key":"1576_CR39","doi-asserted-by":"crossref","unstructured":"Tripathi V, Sixt KM, Gao S, Xu X, Huang J, Weigert R, Zhou M, Zhang YE. Direct regulation of alternative splicing by SMAD3 through PCBP1 is essential to the tumor-promoting role of TGF-beta. Mol Cell. 2016;64:549\u201364.","DOI":"10.1016\/j.molcel.2016.09.013"},{"key":"1576_CR40","doi-asserted-by":"crossref","unstructured":"Zhang T, Huang XH, Dong L, Hu D, Ge C, Zhan YQ, Xu WX, Yu M, Li W, Wang X, et al. PCBP-1 regulates alternative splicing of the CD44 gene and inhibits invasion in human hepatoma cell line HepG2 cells. Mol Cancer. 2010;9:72.","DOI":"10.1186\/1476-4598-9-72"},{"key":"1576_CR41","doi-asserted-by":"crossref","unstructured":"Li Q, Wang Y, Wu S, Zhou Z, Ding X, Shi R, Thorne RF, Zhang XD, Hu W, Wu M. CircACC1 Regulates Assembly and Activation of AMPK Complex under Metabolic Stress. Cell Metab.\u00a02019;2:157-73.","DOI":"10.1016\/j.cmet.2019.05.009"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01576-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-020-01576-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-020-01576-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T23:31:52Z","timestamp":1623886312000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-020-01576-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1576"],"URL":"https:\/\/doi.org\/10.1186\/s13046-020-01576-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"21 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental protocols were approved by the Ethics Committee of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital and performed in accordance with the relevant guidelines and regulations. Written informed consents were obtained from all patients. All animal experiments were approved by the Institutional Animal Care and Use Committee of Naval Medical University (Shanghai, China).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}